While both Democratic and Republican negotiators on coronavirus relief bills seem concerned about crafting legislation to provide a new traunch of funding to support further testing for the COVID-19 virus, Congress-watchers, including Food and Drug Administration supporters, believe a final bill will have to wait until after the US election results are announced later this week.
“The current expectation is that, during the post-election session, Congress will pass a multi-trillion-dollar omnibus bill that combines massive additional COVID-19 relief with FY 21 appropriations bill,” stated Steven Grossman,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?